Methods for diagnosing ovarian cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 26, 2012
Grant Date -
Feb 25, 2010
app pub date -
Sep 11, 2009
filing date -
Mar 28, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry, immunoassay, or other means.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully